New phase 2 findings published in New England Journal of Medicine

CLEVELAND CLINIC-LED TRIAL SHOWS UNPRECEDENTED SLOWING IN PROGRESSIVE MULTIPLE SCLEROSIS

Sunday, September 2, 2018: A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland Clinic. Very limited therapies are currently available for this disabling form of the disease. The definitive results of the phase 2 trial – published in the New England Journal of Medicine…

Don’t let private patients jump the queue, says UNISON

NHS hospitals must stop letting private patients jump to the front of the queue for treatment in world-class facilities at bargain-basement prices, says a new report from health workers’ union UNISON released today (Wednesday). The research suggests that stretched NHS trusts are delivering preferential care to people willing and able to pay for healthcare –…